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Abstract
Background: Lung injury caused by both inhaled dusts and infectious agents depends on increased
availability of iron and metal-catalyzed oxidative stress. Because inhaled particles, such as silica, and
certain infections can cause secondary pulmonary alveolar proteinosis (PAP), we tested the
hypothesis that idiopathic PAP is associated with an altered iron homeostasis in the human lung.
Methods: Healthy volunteers (n = 20) and patients with idiopathic PAP (n = 20) underwent
bronchoalveolar lavage and measurements were made of total protein, iron, tranferrin, transferrin
receptor, lactoferrin, and ferritin. Histochemical staining for iron and ferritin was done in the cell
pellets from control subjects and PAP patients, and in lung specimens of patients without
cardiopulmonary disease and with PAP. Lavage concentrations of urate, glutathione, and ascorbate
were also measured as indices of oxidative stress.
Results: Lavage concentrations of iron, transferrin, transferrin receptor, lactoferrin, and ferritin
were significantly elevated in PAP patients relative to healthy volunteers. The cells of PAP patients
had accumulated significant iron and ferritin, as well as considerable amounts of extracellular
ferritin. Immunohistochemistry for ferritin in lung tissue revealed comparable amounts of this
metal-storage protein in the lower respiratory tract of PAP patients both intracellularly and
extracellularly. Lavage concentrations of ascorbate, glutathione, and urate were significantly lower
in the lavage fluid of the PAP patients.
Conclusion: Iron homeostasis is altered in the lungs of patients with idiopathic PAP, as large
amounts of catalytically-active iron and low molecular weight anti-oxidant depletion are present.
These findings suggest a metal-catalyzed oxidative stress in the maintenance of this disease.
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Background
Pulmonary alveolar proteinosis (PAP; also alveolar protei-
nosis and alveolar lipoproteinosis) has been classified as
a disease entity since 1958 [1]. PAP is characterized by the
massive accumulation of surfactant in the airspaces of the
lower respiratory tract [2,3]. Pulmonary surfactant is a
mixture of phospholipids and proteins essential for lung
homeostasis and alveolar stability. The accumulation of
surfactant in alveolar proteinosis appears to result from
impaired phospholipid clearance rather than over-pro-
duction by type II pneumocytes [4]. PAP is also character-
ized by inflammation with accumulation of abnormal
alveolar macrophages containing intracellular surfactant-
like material, and these phagocytes demonstrate impaired
function [5,6]. Hyperplasia of type II pneumocytes, infil-
tration of lymphocytes and fibroblasts, and fibrosis can
also be observed in PAP [7-9].
In most cases, PAP is idiopathic or primary, but secondary
PAP can accompany inhalational dust exposures (e.g. sil-
ica), infections (especially Mycobacteria, pneumocystis cari-
nii,  nocardia, and cryptococci), malignancies, and
immunosuppressive disorders [10,11]. The etiological
factors in primary PAP remain unknown, but the develop-
ment of antibodies to GM-CSF has led to the postulate
that it is an auto-immune disorder [2]. Lung damage from
infectious agents and inhaled dusts is promoted by the
availability of iron and metal-catalyzed oxidative stress
[12,13]. We tested the hypothesis that primary PAP can be
associated with altered iron homeostasis in the lung by
measuring concentrations of iron and iron-related pro-
teins in lavage from both patients with idiopathic PAP
and healthy control subjects.
Methods
Bronchoalveolar lavage in healthy subjects and patients 
with PAP
Alveolar lavage fluid was obtained from healthy volun-
teers by bronchoscopy with bronchoalveolar lavage (BAL)
at the U.S. Environmental Protection Agency in Chapel
Hill, NC under a protocol approved by the University of
North Carolina [14]. Topical 2% lidocaine was used to
anesthetize the upper airway and larynx. A fiberoptic
bronchoscope was passed into the trachea, where 1%
lidocaine was used for topical anesthesia. The lingula of
the left lung was accessed, where the bronchoscope was
wedged into a subsegment. BAL was performed with 250
mL of 0.9% saline injected serially in 50 mL aliquots. This
procedure was repeated in the right middle lobe. Indices
of iron homeostasis were measured in pooled samples of
lavage fluid from the third, fourth, and fifth aliquots.
Lavage fluid was collected from patients with idiopathic
PAP undergoing whole lung lavage for symptomatic treat-
ment at the Duke University Medical Center [6,11]. The
study protocol was approved by the Duke University Insti-
tutional Review Board. There was no clinical evidence of
infection, including fever, chills, myalgias, elevated tem-
perature, and leukocytosis, in any patient. Procedures
were performed under general anesthesia using independ-
ent lung ventilation with a dual-lumen endotracheal tube.
While the left lung was ventilated with 100% O2, the right
lung was filled with warm 0.9% NaCl at 37°C. After drain-
age of 500 mL of lavage fluid, serial exchanges of 500 mL
each were made using gravity augmented by chest physi-
cal therapy. Lavage was continued until the fluid was
clear, which usually occurred after 15 liters. Samples used
in this investigation were obtained from the second 1.5 L
aliquot of collected fluid.
Lavage iron, tranferrin, transferrin receptor, lactoferrin, 
ferritin, and protein
Since iron is taken up and released by all lung cells [15],
iron homeostasis is maintained by an array of iron han-
dling proteins, redox reactions, and storage mechanisms.
Isolated parameters of iron content are not definitive;
therefore a battery of measurements of uptake, storage
and release proteins is needed to assess iron homeostasis.
We measured lavage concentrations of iron, as well as lev-
els of transferrin, transferrin receptor, lactoferrin, and fer-
ritin as indices of the metal's homeostasis. In addition,
iron and ferritin stains were performed in both lavage cells
and lung tissue.
Iron concentration was measured with a standard colori-
metric assay (Sigma, St. Louis, MO). Transferrin concen-
trations in lavage supernatants were analyzed using a
commercially available kit, controls, and standards from
INCSTAR Corporation (Stillwater, MN). TfR and ferritin
were measured with commercial ELISA kits (R & D Sys-
tems, Minneapolis, MN) as were lactoferrin concentra-
tions (Calbiochem, La Jolla, CA). Lavage protein was
determined with Coomassie Plus Protein Assay Reagent
(Pierce, Rockford, IL) using bovine serum albumin as the
standard.
Iron staining and ferritin immunohistochemistry
Lavage cells (at 1.0 × 106/1.0 mL) were cytocentrifuged
(0.2 mL) onto slides and stained for both iron and ferritin
using Perl's Prussian Blue for iron (n = 4 for healthy sub-
jects and 4 for PAP patients; all PAP cytospins were col-
lected from non-smokers). Immunohistochemistry for
ferritin was performed as reported with rabbit anti-human
ferritin primary antibody (Dako, Carpinteria, CA) [16].
Human lung specimens were obtained from autopsy
archives at Duke University Medical Center (fixed in 10%
formalin). Immunohistochemistry was done on speci-
mens from patients with primary PAP and specimens
from patients with no lung disease listed as a diagnosis onRespiratory Research 2008, 9:10 http://respiratory-research.com/content/9/1/10
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the autopsy (n = 4 for no lung disease and 4 for PAP; all
blocks were collected from non-smokers). Tissue sections
were cut, floated on a protein-free water bath, mounted
on silane treated slides (Fisher, Raleigh, NC), and air-
dried overnight. Sections were stained for iron using Perl's
Prussian Blue. Immunohistochemistry for ferritin was
performed using an human anti-ferritin from Dako [17].
Measurement of ascorbate, glutathione, and urate
Lavage samples were acidified by adding 35 μL of 60%
perchloric acid to 1.0 mL of lavage and 1.5 mL of 4% per-
choloric acid to 0.5 mL of plasma. After 30 min centrifu-
gation at 20,000 g, the supernatant was assayed for
ascorbate and urate using high performance liquid chro-
matography (Waters RCM μ BondaPak C18 column, Mil-
lipore Corporation, Marlborough, MA) with
electrochemical detection (BAS model LC-4B, Bioanalyti-
cal Systems, W. Lafayette, IN) [18]. Total glutathione was
measured in the supernatant by quantifying nonprotein
sulfhydryls, [19].
Statistics
Data are expressed as mean values ± standard deviations.
Differences between two groups were compared using T-
tests of independent means. Significance was assumed at
p < .05.
Results
The healthy subjects that underwent a research bronchos-
copy and bronchoalveolar lavage included 14 male and 6
female with a mean age of 26.5 +/- 3.3 years; all were non-
smokers. In the group of patients with idiopathic PAP
undergoing therapeutic whole lung lavage, there were 17
males and 3 females. The mean age in this cohort was 41.6
+/- 8.3 years; significantly older than the normal subjects.
Among the PAP patients, there were 13 smokers/ex-smok-
ers and 7 non-smokers.
The pooled BAL fluid from healthy volunteers was clear
while that collected from patients with PAP was cloudy
and ranged in color from beige to light pink. The amount
of protein in the lavage collected from PAP patients was
nearly ten-fold higher than that of the healthy volunteers
(1,017 +/- 281 vs. 101 +/- 13 μgrams per mL).
Iron is normally measurable in the BAL fluid of healthy
subjects [20]. The iron concentrations in BAL from our
healthy volunteers were similar to reported values and
were about one hundredth of the serum value [20,21].
BAL iron concentrations from PAP patients were elevated
five-fold relative to those of the healthy volunteers (Figure
1).
Resident cells of the lower respiratory tract produce trans-
ferrin [22], a glycoprotein with anti-oxidant activity in the
lung [23]. The transferrin receptor is also often found in
measurable quantities in BAL fluid [21]. In this study, we
found disparities between the patients and control sub-
jects in BAL concentrations of both transferrin and trans-
ferrin receptor. The mean transferrin level in the lavage
fluid of the PAP patients was at least ten-fold higher than
that of the healthy volunteers (Figure 2A). Similarly, solu-
ble transferrin receptor levels in the lavage of patients with
PAP were also approximately ten-fold higher than in nor-
mal subjects (Figure 2B).
Lactoferrin is a cationic metal-binding glycoprotein syn-
thesized by myeloid cells and secretory epithelium com-
monly found in human mucosal secretions (eg. milk,
tears, semen, and plasma) and in the specific granules of
polymorphonuclear leukocytes. This glycoprotein can be
an alternate route of iron transport, especially in inflam-
mation [24]. Similar to transferrin, lactoferrin levels were
elevated significantly in patients with PAP relative to
healthy volunteers (Figure 3A).
We also measured ferritin, which stores iron in a non cat-
alytically-reactive form. Iron sequestration by ferritin lim-
its its capacity to generate free radicals and confers an
antioxidant function to the protein [25,26]. Ferritin con-
Levels of iron in bronchoalveolar lavage fluid (BAL) from nor- mal volunteers and PAP patients Figure 1
Levels of iron in bronchoalveolar lavage fluid (BAL) from nor-
mal volunteers and PAP patients. Metal concentrations in the 
bronchoalveolar fluid of PAP patients were elevated relative 
to values in healthy controls. All concentrations of iron were 
low relative to those normally found in blood (about 100 
micrograms/dL). * significantly greater than normals; p < 
0.05.
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centration in the normal lung is high, reflecting the direct
interface of the organ with iron particulates in the external
environment [17]. We found measurable concentrations
of ferritin in BAL fluid from normal subjects, while ferritin
levels in lavage fluid of PAP patients were unusually high
(Figure 3B). Moreover, the ferritin levels measured in BAL
fluid in PAP greatly exceed the normal serum levels of fer-
ritin in humans (20 to 200 ng/mL).
In analyses of results from PAP patients only, there were
no significant differences between smokers/ex-smokers,
and non-smokers in lavage concentrations of iron, trans-
ferrin, transferrin receptor, lactoferrin, and ferritin.
BAL cell pellets from PAP patients showed significant iron
accumulation relative to those from healthy subjects. Rep-
resentative photomicrographs are shown in Figure 4.
While only 1 to 2% of lavage cells from healthy subjects
were found to be sideromacrophages, a large number of
the cells in BAL fluid from PAP patients stained for iron.
Similarly, macrophages collected from healthy subjects
occasionally stained positively for ferritin (Figure 4),
whereas ferritin staining was found in many lavage cells
from PAP patients, and was also very intense in the extra-
cellular debris.
A and B. Concentrations of lactoferrin and ferritin in BAL fluid Figure 3
A and B. Concentrations of lactoferrin and ferritin in BAL fluid. Comparable to other iron-transport and storage proteins, lav-
age lactoferrin and ferritin were elevated in these patients. Ferritin concentrations in the PAP patients significantly exceeded 
normal values in serum of healthy subjects even with no correction for dilution occurring during the procedure. * significantly 
greater than normal, healthy subjects; p < 0.05.
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A and B. BAL transferrin and transferrin receptor concentrations in lavage from normals and PAP patients Figure 2
A and B. BAL transferrin and transferrin receptor concentrations in lavage from normals and PAP patients. Levels of this glyc-
oprotein and its receptor were elevated in individuals with alveolar proteinosis. * significantly greater than normals.; p < 0.05.
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Immunohistochemistry of lung sections also demon-
strated significant quantities of ferritin (Figure 5). In lung
sections from individuals dying without lung disease, fer-
ritin was localized to the distal airway epithelium and
alveolar macrophages. In the patients with PAP, ferritin
expression was greatly increased in the distal lower respi-
ratory tract, with intracellular staining of alveolar macro-
phages, and extracellular protein staining within the
alveolar spaces.
Because the evidence of a disturbance in iron homeostasis
was evident in the lungs of patient with PAP, we checked
for evidence of oxidative stress by measuring the concen-
trations of ascorbate, urate, and glutathione in BAL fluid.
The concentrations of all three anti-oxidants were signifi-
cantly depressed in BAL fluid from PAP patients (Figures
6A,6B, and 6C). These results imply the presence of oxida-
tive stress in the lower respiratory tract of PAP patients
consistent with a presence of elevated concentrations of
catalytically active iron.
Discussion
This investigation describes a prominent disorder of iron
homeostasis in the lower respiratory tract of individuals
with primary PAP. Alterations in iron metabolism were
evidenced by elevations in both concentrations of iron
and levels of transferrin, transferrin receptor, lactoferrin,
and ferritin in all patients with PAP. Histology and immu-
nohistology also confirmed excess accumulation of iron
and ferritin in the lungs of these patients. Corresponding
to this iron accumulation, levels of ascorbate, urate, and
glutathione were depressed consistent with the presence
of oxidative stress. These changes in iron homeostasis and
oxidative stress are not attributed to an increase in vascu-
lar permeability among patients with PAP; aberrant trans-
port through a damaged blood-air barrier has been
demonstrated not to occur in alveolar proteinosis [27].
Lung injury following exposures to both infectious agents
and particles/fibers are iron-dependent [12,13]. Notably,
surfactant accumulation in PAP is associated with certain
infections and with inhalation of some particulates. This
association suggested that iron homeostasis might be
abnormal in PAP. A relationship between iron homeosta-
sis, oxidative stress, and altered accumulation and func-
tion of surfactant has been suggested by prior
investigations. For example, iron-loaded transferrin
inhibits surfactant function in the airways of rabbits with
acute respiratory failure, while apotransferrin has no effect
on surfactant function [28]. In addition, iron-loaded
transferrin incubated with H2O2 and a reducing agent
leads to oxidative inactivation of surfactant, while trans-
ferrin without iron has the opposite, antioxidant effect
[28]. Finally, administration of holotransferrin enhances
acute respiratory failure in surfactant-depleted rabbits
[28] while administration of apotransferrin is beneficial
in the same animal model [28]. As the only difference
between the exposures to holotransferrin and apotransfer-
rin is the presence or absence of bound iron, it can be con-
cluded that the metal presents an oxidative stress that
leads to decrements in surfactant function and worsens
respiratory failure.
Blocks of archived lung from autopsies of patients dying with- out a lung disease showed normal staining for ferritin at the  airways and among a few alveolar macrophages (left) Figure 5
Blocks of archived lung from autopsies of patients dying with-
out a lung disease showed normal staining for ferritin at the 
airways and among a few alveolar macrophages (left). Positive 
staining for ferritin was increased in lung tissue of patients 
diagnosed with PAP (right). Expression of the protein in the 
patients with PAP appears to include not only airway epithe-
lium and macrophages but also material filling the alveolar 
spaces. Magnification approximates 200×.
Stain of BAL cell pellets for iron (top) and ferritin (bottom) in  healthy subjects (left) and patients with PAP (right) Figure 4
Stain of BAL cell pellets for iron (top) and ferritin (bottom) in 
healthy subjects (left) and patients with PAP (right). 
Sideromacrophages (stained blue) were rare in normals (top 
left) but increased in number among cells from PAP patients 
(top right). Similarly, those cells staining positively for ferritin 
(stained brown) were few in number in normals (bottom left) 
but were numerous in the cohort with PAP (bottom right). 
Extracellular ferritin appeared to be present. Magnification is 
approximately 100×.Respiratory Research 2008, 9:10 http://respiratory-research.com/content/9/1/10
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Surfactant accumulation in rats after silica exposure also
correlates with the concentration of iron complexed to the
surface of the mineral oxide [29], supporting the associa-
tion of metal-catalyzed oxidative stress with surfactant
metabolism. Other mineral oxide dusts, including cristo-
balite, chrysotile, and kaolinite, have a comparable capac-
ity to coordinate iron and present an oxidative stress to
the lower respiratory tract. Similarly, these particles can be
associated with elevated levels of extracellular surfactant
[30]. Surfactant-enriched material appears to have a
capacity to function as an in vitro target for oxidants cata-
lyzed by Fe3+ complexed to the surface of a particle [29].
Accumulation of surfactant in the lower respiratory tract
occurs following exposure to other forms of oxidative
stress which are also associated with an altered iron home-
ostasis. For example, environmental oxidants such as
ozone and nitrogen dioxide increase the alveolar sur-
factant concentration [31,32]. In addition, chelates and
metals other than iron can either redox cycle or disrupt
iron metabolism, leading to oxidative stress and elevated
surfactant levels in the lung [33-35]. Certain respiratory
infections, such as tuberculosis and nocardiosis, are also
causes of localized alveolar proteinosis, and our group has
previously reported that a substantial fraction of patients
with primary PAP have positive BAL cultures for Mycobac-
terium avium complex (11).
An alteration of iron homeostasis and oxidative stress are
found in the lung during certain infections and particle/
fiber exposures, and for the first time we report idiopathic
PAP among the lung disorders with disturbed iron han-
dling. That both oxidative stress and altered iron homeos-
tasis are present in the lungs of patients with PAP is
associative; however, a causal link is strongly suggested by
the fact that PAP is closely associated with stimuli that cre-
ate significant oxidative stress in the lower respiratory
tract. Oxidative injury following the exposure of the lung
A, B, and C. Lavage concentrations of ascorbate, urate, and glutathione in healthy subjects and patients with PAP Figure 6
A, B, and C. Lavage concentrations of ascorbate, urate, and glutathione in healthy subjects and patients with PAP. There were 
decrements in the concentrations of all three anti-oxidants among patients with PAP. * significant decrease relative to normal, 
healthy subjects; p < 0.05.
Normal PAP
0.00
0.05
0.10
0.15
0.20
0.25
0.30
*
L
a
v
a
g
e
 
a
s
c
o
r
b
a
t
e
 
(
g
/
d
L
)
Normal PAP
0
1
2
3
4
5
6
*
L
a
v
a
g
e
 
u
r
a
t
e
 
(
g
/
d
L
)
Normal PAP
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
*
L
a
v
a
g
e
 
g
l
u
t
a
t
h
i
o
n
e
 
(
g
/
d
L
)
A B
CRespiratory Research 2008, 9:10 http://respiratory-research.com/content/9/1/10
Page 7 of 8
(page number not for citation purposes)
to microorganisms or particulates could contribute to dis-
ease pathogenesis in primary PAP by causing surfactant
oxidation and dysfunction, and its subsequent accumula-
tion [29].
An accumulation of iron in lung tissue with aging has
been demonstrated [36]. Some increase in lavage iron is
certainly predicted with aging but this has not been con-
firmed in any study. Based on these reported changes in
tissue non-heme iron concentrations, the differences in
age observed in this study between the healthy subjects
and PAP patients cannot account for the observed dispar-
ities in iron and iron-related proteins. Relative to aging,
smoking will have a greater impact on lavage concentra-
tions of iron and iron-related proteins. Iron concentra-
tions also increase in the lavage from cigarette smokers
[37]. Concentrations of specific iron-related proteins in
lavage fluid have not been reported except for ferritin and
this storage protein increased in the lavage fluid of smok-
ers [37,38]. Smoking may contribute to some portion of
the differences in iron and iron-related proteins observed
in this study between the healthy subjects and PAP
patients. However, smoking fails to explain disparities
between these two cohorts as there were no significant dif-
ferences in lavage concentrations of iron and iron-related
proteins between smokers/ex-smokers and non-smokers
among the PAP patients. In addition, the magnitude of
changes observed reported in previous studies among
smokers does not approach those observed in this investi-
gation among PAP patients.
Lavage iron and ferritin concentrations are similarly ele-
vated among patients with acute respiratory distress syn-
drome [39] and pneumoconiosis[40], and following
transplantation [41]. However, the disturbance in iron
homeostasis among PAP patients reported in this investi-
gation is exceptional in its magnitude with 5- to 20-fold
elevations in concentrations of the metal and specific
iron-related proteins.
Since reactive oxygen species (ROS) generated by excess
iron damages biological molecules, optimal homeostasis
requires extremely low concentrations of free iron. The
transport and storage of iron is with all coordination sites
complexed to prevent excess ROS generation. The host
responds to elevated concentrations of available iron by
sequestering it in the storage protein ferritin. This requires
transporting the metal intracellularly, usually by the glyc-
oprotein transferrin, which uses a membrane-bound
receptor TfR. Lactoferrin-mediated metal transport is an
alternative mechanism for metal transfer after exposures
to microbes and particles/fibers, and is important for
transport of iron to ferritin in monocytes and macro-
phages during inflammation. A novel aspect of our data is
the finding that TfR in PAP lavage fluid is increased
despite elevated soluble iron levels in the lung. With expo-
sure to iron, many cell types rapidly down regulate TfR
expression to limit iron uptake. However, with elevations
in available iron observed during inflammation, mono-
cytes and macrophages actually increase TfR expression
[42,43]. Increased TfR in the BAL of PAP patients may
reflect a defensive attempt to transport and sequester ele-
vated concentrations of metal that occur in inflammatory
injuries.
Conclusion
We conclude that primary PAP is associated with an
altered iron homeostasis in the lung. Our findings suggest
the presence of metal-catalyzed oxidative stress in this rare
lung disease. They also imply that, rather than being a uni-
form disease with a single etiology, PAP can be a pattern
of injury associated with loss of iron homeostasis in the
lower respiratory tract and a resultant oxidative stress.
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